Radiopharmaceutical Production (FDG)
Fluorodeoxyglucose (FDG) is a radiopharmaceutical used in PET/CT imaging to support diagnosis and treatment planning. RMC produces FDG using cyclotron-based isotope generation followed by synthesis and quality control.
What is FDG?
FDG is a glucose analog labeled with fluorine-18. After administration, it accumulates in tissues with increased glucose metabolism and can be detected by PET/CT imaging.
Production Overview
- Isotope production using the cyclotron.
- Radiochemical synthesis in controlled modules.
- Quality control testing before release.
Clinical Context
FDG PET/CT is used across oncology, neurology, and cardiology, subject to clinical protocols and physician judgment.